Zomedica Corp (ZOM)
0.1203
0.00 (0.00%)
USD |
NYAM |
Nov 05, 11:30
Zomedica Revenue (Quarterly): 6.131M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.131M |
| March 31, 2024 | 6.262M |
| December 31, 2023 | 7.337M |
| September 30, 2023 | 6.347M |
| June 30, 2023 | 6.02M |
| March 31, 2023 | 5.482M |
| December 31, 2022 | 6.157M |
| Date | Value |
|---|---|
| September 30, 2022 | 4.776M |
| June 30, 2022 | 4.246M |
| March 31, 2022 | 3.751M |
| December 31, 2021 | 4.081M |
| September 30, 2021 | 0.023M |
| June 30, 2021 | 0.016M |
| March 31, 2021 | 0.014M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.014M
Minimum
Mar 2021
7.337M
Maximum
Dec 2023
4.332M
Average
5.129M
Median
Revenue (Quarterly) Benchmarks
| Standard BioTools Inc | 44.97M |
| Ainos Inc | -- |
| LENSAR Inc | 12.64M |
| Intelligent Bio Solutions Inc | 0.7278M |
| Adagio Medical Holdings Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.93M |
| Total Expenses (Quarterly) | 15.17M |
| EPS Diluted (Quarterly) | -0.024 |
| Enterprise Value | 40.25M |
| Gross Profit Margin (Quarterly) | 71.15% |
| Profit Margin (Quarterly) | -390.3% |
| Earnings Yield | -47.38% |
| Normalized Earnings Yield | -25.90 |